RxDoctor Payments Data

Nicholas Prayson

Interventional Pain Medicine · Wooster, OHNPI 1073002077

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 90.6% of the total across 38 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 18 manufacturers reported payments, led by Nevro Corp. at 29.9% of the total. Reporting peaked in 2024 at $598 and has fallen 72.5% since, to $164 in 2025. That places this record below the midpoint for interventional pain medicine clinicians in OH, where the typical reported total is $5,193.

$1,805in general payments, 2019–2025

Across 38 payments — averaging $47.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Nevro Corp.$539
  • Stryker$400
  • Medtronic$315
  • Abbott$116
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$75
  • Averitas Pharma Inc.$50
  • plus $310 from 12 others

What the payments were for

  • Travel & lodging$1709%
  • Food & beverage$1,63591%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,805 in reported general payments places this provider in the 20th percentile of 67 interventional pain medicine providers in Ohio.

See all interventional pain medicine providers in Ohio

Medicare billing

Part B allowed, 2024
$90,403
Medicare patients
109
Services billed
1,231

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Pregabalin33$1,622
Duloxetine Hcl34$898
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen32$698
Gabapentin101$648
Baclofen41$625
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen44$526
Tizanidine Hcl68$424
Tramadol Hcl70$280
Oxycodone Hcl39$245
Cyclobenzaprine Hcl15$228
Meloxicam43$83
Methylprednisolone11$49

Paid to pharmacies, not to this prescriber.

Other interventional pain medicine in Wooster

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →